1. Home
  2. NTRA vs K Comparison

NTRA vs K Comparison

Compare NTRA & K Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NTRA
  • K
  • Stock Information
  • Founded
  • NTRA 2003
  • K 1906
  • Country
  • NTRA United States
  • K United States
  • Employees
  • NTRA N/A
  • K N/A
  • Industry
  • NTRA Medical Specialities
  • K Packaged Foods
  • Sector
  • NTRA Health Care
  • K Consumer Staples
  • Exchange
  • NTRA Nasdaq
  • K Nasdaq
  • Market Cap
  • NTRA 24.9B
  • K 27.6B
  • IPO Year
  • NTRA 2015
  • K N/A
  • Fundamental
  • Price
  • NTRA $192.81
  • K $83.02
  • Analyst Decision
  • NTRA Strong Buy
  • K Hold
  • Analyst Count
  • NTRA 17
  • K 1
  • Target Price
  • NTRA $196.24
  • K $83.50
  • AVG Volume (30 Days)
  • NTRA 1.1M
  • K 2.4M
  • Earning Date
  • NTRA 11-07-2025
  • K 10-30-2025
  • Dividend Yield
  • NTRA N/A
  • K 2.79%
  • EPS Growth
  • NTRA N/A
  • K 44.81
  • EPS
  • NTRA N/A
  • K 3.82
  • Revenue
  • NTRA $1,964,250,000.00
  • K $12,643,000,000.00
  • Revenue This Year
  • NTRA $24.17
  • K $1.87
  • Revenue Next Year
  • NTRA $15.57
  • K $2.28
  • P/E Ratio
  • NTRA N/A
  • K $21.75
  • Revenue Growth
  • NTRA 44.38
  • K N/A
  • 52 Week Low
  • NTRA $119.29
  • K $76.48
  • 52 Week High
  • NTRA $198.99
  • K $83.22
  • Technical
  • Relative Strength Index (RSI)
  • NTRA 68.54
  • K 68.69
  • Support Level
  • NTRA $183.88
  • K $82.59
  • Resistance Level
  • NTRA $198.99
  • K $83.14
  • Average True Range (ATR)
  • NTRA 6.55
  • K 0.21
  • MACD
  • NTRA 1.09
  • K -0.11
  • Stochastic Oscillator
  • NTRA 80.07
  • K 85.89

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

About K Kellanova

Following its split from the North American cereal business in October 2023, Kellanova (previously the global snacking arm of Kellogg) has operated as a leading global manufacturer and marketer of salty snacks, snack bars, frozen breakfast fare, meat alternatives, and other packaged foods. Its offerings are manufactured in around 20 countries and marketed in over 180. Its product mix includes well-known brands such as Pringles, Cheez-It, Rice Krispies Treats, Pop-Tarts, Eggo, Nutri-Grain, and Morningstar Farms. Sales beyond its home turf account for about two thirds of Kellanova's consolidated sales base. Mars is slated to acquire the recently independent business in a nearly $36 billion deal.

Share on Social Networks: